FXN mRNA expression was quite similar in FRDA patient cells, negative control clones and miniSINEUP-FXN clones, confirming SINEUPs’ post-transcriptional mode of action (Figure 7C). The gene discussed is FXN; the disease is Friedreich ataxia.